By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Catabasis Pharmaceuticals, Inc. 

161 First Street, Suite 1A

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-349-1971 Fax: 617-273-2637


SEARCH JOBS


Industry
Pharmaceutical






Company News
Catabasis Pharmaceuticals, Inc. Receives FDA Orphan Drug Designation For CAT-1004 For The Treatment Of Duchenne Muscular Dystrophy 11/24/2014 9:24:13 AM
Catabasis Pharmaceuticals, Inc. Names Angelika Fretzen, Ph.D., Vice President Of Development 11/18/2014 12:21:10 PM
Catabasis Pharmaceuticals, Inc. Management To Present At October Investor Conferences 9/30/2014 10:08:06 AM
Catabasis Pharmaceuticals, Inc. To Present At International Congress Of The World Muscle Society 9/29/2014 11:57:42 AM
Catabasis Pharmaceuticals, Inc. To Present At Wedbush 2014 Life Sciences Management Access Conference 8/6/2014 9:39:27 AM
Catabasis Pharmaceuticals, Inc. To Present At Parent Project Muscular Dystrophy (PPMD) Annual Connect Conference And New Directions In Biology And Disease Of Skeletal Muscle Conference 6/24/2014 8:45:50 AM
Catabasis Pharmaceuticals, Inc. Announces Issuance Of Three New US Patents For CAT-1000 Series 6/11/2014 8:24:34 AM
Catabasis Pharmaceuticals, Inc. Demonstrates CAT-2003 Lowers Fed And Fasting Triglycerides In Studies Presented At Lipid Conferences 5/5/2014 6:41:30 AM
Catabasis Pharmaceuticals, Inc. Describes Modulation Of SREBP As Mechanism For CAT-2003 5/1/2014 2:06:20 PM
Catabasis Pharmaceuticals, Inc. To Present CAT-2003 Data At Upcoming Lipid Conferences 4/25/2014 7:04:30 AM
1234
//-->